Sponsor: Presage Biosciences
Sponsor Study ID: PBI-MST-01
Study Title: A Phase 0 Master Protocol Using the CIVO Platform to Evaluate Intratumoral Microdoses of Anti-Cancer Therapies in Patients with Solid Tumors.
CTO #: 103736
NCT Number:
Phase: Early Phase I
Protocol Type: Basic Science
Age Group: Adults
Disease Sites: Lip, Oral Cavity and Pharynx, Larynx, Melanoma, Skin
Study Objectives: